ArticlePharmacogenetics and genomics2012

A genome-wide association study identifies four genetic markers for hematological toxicities in cancer patients receiving gemcitabine therapy.

Kazuma Kiyotani et al.PubMed ↗Publisher ↗

No numbers read from the abstract.